Andere talen Profound Medical Corp.

Aandelen

PRN

CA74319B5027

Vertraagde tijd Toronto S.E. Andere beurzen 18:16:17 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,36 ^CAD	+2,98%		-1,33%	-6,67%

13/03	Transcript : Profound Medical Corp. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
11/03	PROFOUND MEDICAL CORP. : Alliance Global Partners handhaaft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	22/04
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
Profound Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment	07/03
Profound Medical Brief: Announcing promotion of Mathieu Burtnyk, from SVP Product Leader to Chief Operating Officer	07/03
Profound Medical Brief: Q4 2023 net loss was approximately US$8.9 million, or $0.42 per common share	07/03
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	07/03
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	07/03
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	04/03
Profound Medical Collaborates With Siemens Healthineers to Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical Corp. Enters into A Non-Exclusive Collaboration with Siemens Healthineers	27/02
Profound Medical Brief: Entering Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	15/02
Profound Medical Up 1.9% In US After Hours As Announces Non-Brokered Private Placement	16/01
Profound Medical Announces Non-Brokered Private Placement	16/01
Profound Medical Corp. announced that it expects to receive $2.937503 million in funding	16/01
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)	04/01
Profound Medical Brief: Adds Top priorities for 2024 will be to further increase Its TULSA-PRO installed base, support increased system utilization, complete its ongoing Level 1 CAPTAIN trial	03/01
Profound Medical Brief: For Full year 2023, Anticipates total revenues to be in Approximate range of US$7.1 million to $7.2 million	03/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Profound Medical Corp.

Aandelen

PRN

CA74319B5027

Andere talen

Filters